Literature DB >> 9546641

Role of nucleoside transport and purine release in a rabbit model of myocardial stunning.

A S Abd-Elfattah1, R P Maddox, M E Jessen, I M Rebeyka, A S Wechsler.   

Abstract

Previously, we have demonstrated the role of nucleoside transport and purine release in post-ischemic reperfusion injury (myocardial stunning) in several canine models of ischemia. Since rabbits are deficient of xanthine oxidase, it is not known whether selective blockade of purine release is beneficial in a rabbit model of coronary artery occlusion and reperfusion (stunning). Therefore, we determined the hemodynamic and metabolic correlates in response to myocardial stunning in the presence or absence of selective nucleoside transport blocker (p-nitrobenzylthioinosine, NBMPR) and adenosine deaminase inhibitor (erythro-9-(2-hydroxy-3-nonyl)adenine, EHNA). Sixty adult anaesthetized rabbits were surgically prepared for hemodynamic measurements. After stabilization period, the left anterior descending coronary artery was occluded for 15 min and reperfused for 30 min. Transmural myocardial biopsies were obtained from the ischemic LAD area and from the non-ischemic posterior (circumflex, CFX) segment of the myocardium. Rabbits (n = 60) were randomly assigned to either the control or the EHNA/NBMPR-treated group (n = 30 each). Each group was further divided to either functional or metabolic groups (n = 15 each subgroup). Each animal received intravenously 30 ml of either a vehicle solution or 100 M EHNA and 25 M NBMPR 10 min before ischemia. Although administration of EHNA/NBMPR did not affect the heart rate, it did cause mild hypotension (about 20-30%). Fifteen minutes of LAD occlusion resulted in significant ATP depletion and concomitant accumulation of nucleosides in both groups (p < 0.05 vs. baseline and non-ischemic CFX segment). AMP was higher in the LAD compared to the CFX segment. Significant accumulation of adenosine was observed in the treated group compared to the control group. It is concluded that EHNA/NBMPR induced site specific entrapment of adenosine of nucleoside transport in the rabbit heart, in vivo.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9546641

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  23 in total

1.  Adenosine-induced release of cyclic adenosine 3',5'-monophosphate from the left ventricle in the anaesthetized intact dog.

Authors:  T Huynh-Thu; J Lammerant
Journal:  J Physiol       Date:  1978-06       Impact factor: 5.182

2.  Adenosine as inhibitor of myocardial effects of catecholamines.

Authors:  J Schrader; G Baumann; E Gerlach
Journal:  Pflugers Arch       Date:  1977-11-25       Impact factor: 3.657

Review 3.  Metabolic intervention to affect myocardial recovery following ischemia.

Authors:  M K Pasque; A S Wechsler
Journal:  Ann Surg       Date:  1984-07       Impact factor: 12.969

4.  Inhibition by adenosine of catecholamine-induced increase in rat atrial contractility.

Authors:  J B Rockoff; J G Dobson
Journal:  Am J Physiol       Date:  1980-09

5.  Prolonged myocardial nucleotide depletion after brief ischemia in the open-chest dog.

Authors:  J L Swain; R L Sabina; P A McHale; J C Greenfield; E W Holmes
Journal:  Am J Physiol       Date:  1982-05

6.  Prolonged depletion of ATP and of the adenine nucleotide pool due to delayed resynthesis of adenine nucleotides following reversible myocardial ischemic injury in dogs.

Authors:  K A Reimer; M L Hill; R B Jennings
Journal:  J Mol Cell Cardiol       Date:  1981-02       Impact factor: 5.000

7.  Reactive oxygen species may cause myocardial reperfusion injury.

Authors:  D A Peterson; R W Asinger; K J Elsperger; D C Homans; J W Eaton
Journal:  Biochem Biophys Res Commun       Date:  1985-02-28       Impact factor: 3.575

8.  Adenosine metabolism and myocardial preservation. Consequences of adenosine catabolism on myocardial high-energy compounds and tissue blood flow.

Authors:  J E Foker; S Einzig; T Wang
Journal:  J Thorac Cardiovasc Surg       Date:  1980-10       Impact factor: 5.209

9.  Reduction in experimental infarct size by recombinant human superoxide dismutase: insights into the pathophysiology of reperfusion injury.

Authors:  G Ambrosio; L C Becker; G M Hutchins; H F Weisman; M L Weisfeldt
Journal:  Circulation       Date:  1986-12       Impact factor: 29.690

10.  Enhancement of recovery of myocardial function by oxygen free-radical scavengers after reversible regional ischemia.

Authors:  M L Myers; R Bolli; R F Lekich; C J Hartley; R Roberts
Journal:  Circulation       Date:  1985-10       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.